166 related articles for article (PubMed ID: 3278172)
1. 12th codon mutation resulting in c-N-ras activation in acute myelogenous leukemia.
Needleman SW; Devine SE; Kraus MH
Leukemia; 1988 Feb; 2(2):91-3. PubMed ID: 3278172
[TBL] [Abstract][Full Text] [Related]
2. Infrequent ras activation in chronic myelogenous leukemia (CML): activating 61st codon mutation in the CML-derived cell line, IM-9.
Needleman SW; Gutheil JC; Kapil V; Mane SM
Leukemia; 1989 Nov; 3(11):827-9. PubMed ID: 2682048
[TBL] [Abstract][Full Text] [Related]
3. N-RAS gene activation in acute myeloid leukemia: association with expression of interleukin-6.
Lübbert M; Oster W; Knopf HP; McCormick F; Mertelsmann R; Herrmann F
Leukemia; 1993 Dec; 7(12):1948-54. PubMed ID: 8255093
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia.
Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP
Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347
[TBL] [Abstract][Full Text] [Related]
5. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
[TBL] [Abstract][Full Text] [Related]
6. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of ras gene activation in myeloid leukemic cells.
Lübbert M; Jonas D; Miller CW; Herrmann F; Mertelsmann R; McCormick F; Koeffler HP
Oncogene; 1990 Apr; 5(4):583-7. PubMed ID: 2183160
[TBL] [Abstract][Full Text] [Related]
8. Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia.
Nakagawa T; Saitoh S; Imoto S; Itoh M; Tsutsumi M; Hikiji K; Nakamura H; Matozaki S; Ogawa R; Nakao Y
Oncology; 1992; 49(2):114-22. PubMed ID: 1574246
[TBL] [Abstract][Full Text] [Related]
9. [Oncogenes in human leukemia].
Takaku F
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):617-23. PubMed ID: 2650633
[TBL] [Abstract][Full Text] [Related]
10. Low frequency of ras oncogene mutations in Philadelphia-positive acute leukemia and report of a novel mutation H61 Leu in a single case.
Urbano-Ispizua A; Gill R; Matutes E; Levi S; Wiedemann LM; Catovsky D; Marshall CJ
Leukemia; 1992 Apr; 6(4):342-6. PubMed ID: 1588796
[TBL] [Abstract][Full Text] [Related]
11. [Activation of ras oncogene in myelodysplastic syndrome and acute myelogenous leukemia].
Hirai H; Hirano N; Yazaki Y
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1090-7. PubMed ID: 2053767
[TBL] [Abstract][Full Text] [Related]
12. Activation of Harvey ras oncogene by mutation at codon 12 is very rare in hemopoietic malignancies.
Browett PJ; Yaxley JC; Norton JD
Leukemia; 1989 Jan; 3(1):86-8. PubMed ID: 2642580
[TBL] [Abstract][Full Text] [Related]
13. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.
Nagata Y; Abe M; Kobayashi K; Yoshida K; Ishibashi T; Naoe T; Nakayama E; Shiku H
Cancer Res; 1990 Feb; 50(3):480-2. PubMed ID: 2404571
[TBL] [Abstract][Full Text] [Related]
14. Activated c-N-ras in radiation-induced acute nonlymphocytic leukemia: twelfth codon aspartic acid.
Gumerlock PH; Meyers FJ; Foster BA; Kawakami TG; deVere White RW
Radiat Res; 1989 Feb; 117(2):198-206. PubMed ID: 2646654
[TBL] [Abstract][Full Text] [Related]
15. The incidence and prognostic significance of mutations in codon 13 of the N-ras gene in acute myeloid leukemia.
Coghlan DW; Morley AA; Matthews JP; Bishop JF
Leukemia; 1994 Oct; 8(10):1682-7. PubMed ID: 7934163
[TBL] [Abstract][Full Text] [Related]
16. ras oncogene activation and occupational exposures in acute myeloid leukemia.
Taylor JA; Sandler DP; Bloomfield CD; Shore DL; Ball ED; Neubauer A; McIntyre OR; Liu E
J Natl Cancer Inst; 1992 Nov; 84(21):1626-32. PubMed ID: 1433344
[TBL] [Abstract][Full Text] [Related]
17. c-fms point mutations in acute myeloid leukemia: fact or fiction?
Springall F; O'Mara S; Shounan Y; Todd A; Ford D; Iland H
Leukemia; 1993 Jul; 7(7):978-85. PubMed ID: 8321048
[TBL] [Abstract][Full Text] [Related]
18. Direct sequencing of amplified genomic fragments documents N-ras point mutations in myeloid leukemia.
Collins SJ
Oncogene Res; 1988 Sep; 3(2):117-23. PubMed ID: 3067186
[TBL] [Abstract][Full Text] [Related]
19. SSCP detection of N-ras promoter mutations in AML patients.
Thorn J; Molloy P; Iland H
Exp Hematol; 1995 Sep; 23(10):1098-103. PubMed ID: 7656930
[TBL] [Abstract][Full Text] [Related]
20. Activated ras alleles in human carcinoma of the prostate are rare.
Gumerlock PH; Poonamallee UR; Meyers FJ; deVere White RW
Cancer Res; 1991 Mar; 51(6):1632-7. PubMed ID: 1998954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
